Search by property

Jump to navigation Jump to search

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

Search by property

A list of all pages that have property "AnswerE" with value "Inhibits hypoxanthine-guanine phosphoribosyltransferase". Since there have been only a few results, also nearby values are displayed.

Showing below up to 26 results starting with #1.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)


    

List of results

  • WBR0580  + (Increase in arterial pCO2 and decrease in arterial pO2)
  • WBR0949  + (Increase in carbon monoxide (CO))
  • WBR0192  + (Increase in hospitalizations and no effect on overall mortality)
  • WBR0732  + (Increase in insulin sensitivity)
  • WBR0860  + (Increase in proton gradient across electron transport chain)
  • WBR0055  + (Increase of cAMP by intrinsic enzymatic activity)
  • WBR0369  + (Increased norepinephrine, Decreased GABA, Decreased serotonin)
  • WBR0864  + (Increased residual volume)
  • WBR0877  + (Increased urinary NGAL (neutrophil gelatinase-associated lipocalin))
  • WBR1106  + (Increases G<sub>q</sub> activity)
  • WBR0291  + (Increases the concentration of cyclic AMP (cAMP) via calmodulin-activated adenylyl cyclase activity.)
  • WBR0047  + (India ink)
  • WBR0224  + (Inferior petrosal sinus sampling.)
  • WBR0101  + (Infertility)
  • WBR0175  + (Inflammation of the entire small and large bowels.)
  • WBR0044  + (Influenza virus)
  • WBR0161  + (Inherited disorder characterized by substitution of glutamic acid with valine)
  • WBR0434  + (Inhibition of DNA polymerase activity)
  • WBR0536  + (Inhibition of GABA reuptake)
  • WBR0487  + (Inhibition of protein kinase)
  • WBR0349  + (Inhibition of thromboxane A2 production)
  • WBR0235  + (Inhibitor of aminoacyl tRNA entry into ribosome)
  • WBR0252  + (Inhibits DNA gyrase)
  • WBR0056  + (Inhibits cell wall synthesis by binding and inactivating proteins)
  • WBR0478  + (Inhibits ergosterol synthesis)
  • WBR0157  + (Inhibits hypoxanthine-guanine phosphoribosyltransferase)
  • WBR0507  + (Inhibits protein elongation by blocking peptidyl-transferase)
  • WBR0306  + (Initiate HAART and trimethoprim-sulphamethoxazole)
  • WBR1028  + (Initiate positive pressure ventilation in preparation for pericardiocentesis)
  • WBR0488  + (Inositol triphosphate receptor)
  • WBR0866  + (Inositol-based phospholipids)
  • WBR1121  + (Insulin)
  • WBR0555  + (Insulin secretion and sensitivity)
  • WBR0808  + (Insulin, Gastric H<sup>+</sup>, GI Motility)
  • WBR0643  + (Interferes with cell membrane leading to postassium leak and depolarization.)
  • WBR0773  + (Interferon-alpha (INF-alpha))
  • WBR0491  + (Interleukin 12)
  • WBR0490  + (Interleukin 5)
  • WBR0171  + (Intracranial hemorrhage)
  • WBR1118  + (Intravenous clindamycin)
  • WBR1067  + (Intravenous diuretics)
  • WBR1068  + (Intravenous diuretics)
  • WBR1064  + (Intravenous gentamicin sulfate)
  • WBR1062  + (Intravenous vancomycin hydrochloride)
  • WBR1063  + (Intravenous vancomycin hydrochloride)
  • WBR0963  + (Intrinsic factor)
  • WBR0486  + (Iron replacement)
  • WBR0622  + (Iron studies and genetic testing)
  • WBR0185  + (Isocitrate dehydrogenase 1/2 (IDH1/IDH2) mutation)
  • WBR0254  + (Isolated protein C deficiency)
  • WBR0363  + (It commonly presents with splitting as a coping method)